WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R07 OTHER RESPIRATORY SYSTEM PRODUCTS
R07A OTHER RESPIRATORY SYSTEM PRODUCTS

This group comprises lung surfactants and respiratory stimulants.
Caffeine is classified in N06B - Psychostimulants, agents used for ADHD and nootropics. See also comments under R07AB - Respiratory stimulants.


R07AA Lung surfactants

This group comprises surface-tension lowering agents used in respiratory distress syndrome. Combinations of different lung surfactants are classified in R07AA30, e.g. sinapultide in combination with other lung surfactants are classified here.

The DDDs of colfosceril palmitate and natural phospholipids are based on the treatment of respiratory distress syndrome in neonates, and correspond to the treatment of children weighing 1.6 kg.

R07AB Respiratory stimulants

Centrally acting respiratory stimulants mainly used for asthma and similar respiratory diseases (e.g. theophylline) are classified in R03D. Other respiratory stimulants are classified here. This group includes plain and combined preparations.
Combinations with respiratory stimulants and caffeine are classified in this group. Plain caffeine preparations are classified in
N06B - Psychostimulants, agents used for ADHD and nootropics.

This group includes various drugs used on different indications. The DDDs are therefore established individually for each ATC 5th level.

R07AX Other respiratory system products

This group comprises preparations used for respiratory disorders, which cannot be classified in the preceding groups.
Nitric oxide is classified here, other medical gases, see V03AN.

Last updated: 2019-12-16